Results 111 to 120 of about 39,976 (222)
Spatiotemporal dynamics of β‐arrestin‐mediated Src activation in 5‐HT7 receptor signaling pathway
GPCRs induce distinct cellular responses via G protein‐ or β‐arrestin‐mediated signaling pathways. This study revealed that β‐arrestin‐biased 5‐HT7R ligand induces slow, sustained Src activation, contrasting with transient G protein‐mediated activation.
Hyunbin Kim +8 more
wiley +1 more source
Morphology and Micromorphological Examination of Giant Subcutaneous Fibrosarcoma in Goats: Five Cases. [PDF]
Yadav SK, Yadav S.
europepmc +1 more source
RAS Inhibitor RMC‐7977 Blocks Vascular Overgrowth of NRASQ61R Mutant Endothelial Cells
ABSTRACT RAS mutations occur in patients with several types of vascular anomalies, but effective treatments remain limited. To address this need, we evaluated the RAS (ON) multi‐selective inhibitor RMC‐7977 in human endothelial cells (ECs) expressing the NRASQ61R mutation found in kaposiform lymphangiomatosis (KLA).
Sara Alharbi +6 more
wiley +1 more source
Biomimetic dual-driven STING nanoagonist orchestrates neoadjuvant mild photo-immunotherapy for fibrosarcoma. [PDF]
Wang Z +11 more
europepmc +1 more source
ABSTRACT Aim Kaposiform haemangioendothelioma is a rare vascular tumour. Management has evolved over the last two decades, with most cases receiving vincristine or sirolimus. We aim to describe our experience with managing this tumour, with a focus on the safety and efficacy of vincristine.
Bronwen Kirk +4 more
wiley +1 more source
Fibrosarcoma Originating in the Tail of a Cat. [PDF]
Yuki M, Hirano T, Yokota S, Tanabe M.
europepmc +1 more source
Childhood Ayme-Gripp syndrome: A case report. [PDF]
Xu J, Song X, Jia W, Zou C.
europepmc +1 more source
Juvenile Fibrosarcoma of the Parotid Gland in an Adult Patient: A Case Report. [PDF]
Escobar Howard M +2 more
europepmc +1 more source
Recurrence Rates for Mandibular Fibrosarcoma Associated With Mandibular Canal Invasion Following Mandibulectomy Procedures in Dogs. [PDF]
Johnson CP +11 more
europepmc +1 more source

